Lasa Supergenerics has reported results for fourth quarter and year ended March 31, 2022.
The company has reported over 3-fold jump in its net profit at Rs 12.28 crore for the quarter under review as compared to Rs 3.80 crore for the same quarter in the previous year. Total income of the company increased by 30.96% at Rs 51.22 crore for Q4FY22 as compared Rs 39.11 crore for the corresponding quarter previous year.
For the year ended March 31, 2022, the company has reported net loss of Rs 5.37 crore as compared to net profit of Rs 22.78 crore for the previous year. Total income of the company decreased by 32.24% at Rs 137.18 crore for year under review as compared to Rs 202.44 crore for year ended March 31, 2021.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1849.05 |
Dr. Reddys Lab | 1274.25 |
Cipla | 1553.20 |
Lupin | 2184.00 |
Zydus Lifesciences | 1001.85 |
View more.. |